Medicine
Tissueblue 0.0125 mg/0.5 mL injection
Tissueblue 0.0125 mg/0.5 mL injection is a prescription medicine containing Brilliant blue g for intraocular, ophthalmic use, marketed by DORC Dutch Ophthalmic Research Center (International), with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
TissueBlue 0.025% should be stored at 15°C to 25°C (59°F to 77°F). Protect…
Key facts
- Active ingredient (INN)
- Brilliant blue g
- Brand
- Tissueblue
- Strength
- 0.0125 mg/0.5 mL
- Dosage form
- Injection
- Route
- Intraocular, ophthalmic
- Packs
- 10 pouches of 0.5 mL
- Marketing authorisation holder
- DORC Dutch Ophthalmic Research Center (International)
- Manufacturer
- DORC Dutch Ophthalmic Research Center (International)
- Origin register
- US FDA, United States
- Storage
- TissueBlue 0.025% should be stored at 15°C to 25°C (59°F to 77°F). Protect from light, frost and moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 31 December 2019
- Identifiers
- DailyMed set ID 9d4b28b4-c582-4e2c-abd9-f7e203378e2dNDC 68803-722Application NDA209569
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 pouch in 1 carton / 1 syringe, glass in 1 pouch / .5 mL in 1 syringe, glass | 68803-722-05 | DORC Dutch Ophthalmic Research Center (International) | 31 December 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 20 December 2019 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Brilliant blue g is a disclosing agent indicated to selectively stain the internal limiting membrane (ILM). It is available as injection for intraocular and ophthalmic use. MedsAcross supplies Brilliant blue g for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Brilliant blue gFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- TISSUEBLUE prescribing information (DORC Dutch Ophthalmic Research Center (International)) · U.S. National Library of Medicine, DailyMed
Need Tissueblue 0.0125 mg/0.5 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.